|
1
|
Sakai Y, Ito S, Hida T, Ito K, Harada A
and Watanabe K: Clinical outcome of lumbar spinal stenosis based on
new classification according to hypertrophied ligamentum flavum. J
Orthop Sci. 22:27–33. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Shafaq N, Suzuki A, Terai H, Wakitani S
and Nakamura H: Cellularity and cartilage matrix increased in
hypertrophied ligamentum flavum: Histopathological analysis
focusing on the mechanical stress and bone morphogenetic protein
signaling. J Spinal Disord Tech. 25:107–115. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Salimi H, Suzuki A, Habibi H, Orita K,
Hori Y, Yabu A, Terai H, Tamai K and Nakamura H: Biglycan
expression and its function in human ligamentum flavum. Sci Rep.
11:48672021. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang B, Gao C, Zhang P, Sun W, Zhang J and
Gao J: The increased motion of lumbar induces ligamentum flavum
hypertrophy in a rat model. BMC Musculoskelet Disord. 22:3342021.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sairyo K, Biyani A, Goel VK, Leaman DW,
Booth R Jr, Thomas J, Ebraheim NA, Cowgill IA and Mohan SE: Lumbar
ligamentum flavum hypertrophy is due to accumulation of
inflammation-related scar tissue. Spine (Phila Pa 1976).
32:E340–E347. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Saito T, Hara M, Kumamaru H, Kobayakawa K,
Yokota K, Kijima K, Yoshizaki S, Harimaya K, Matsumoto Y, Kawaguchi
K, et al: Macrophage infiltration is a causative factor for
ligamentum flavum hypertrophy through the activation of collagen
production in fibroblasts. Am J Pathol. 187:2831–2840. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Park JO, Lee BH, Kang YM, Kim TH, Yoon JY,
Kim H, Kwon UH, Lee KI, Lee HM and Moon SH: Inflammatory cytokines
induce fibrosis and ossification of human ligamentum flavum cells.
J Spinal Disord Tech. 26:E6–E12. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang L, Chang M, Tian Y, Yan J, Xu W, Yuan
S, Zhang K and Liu X: The role of Smad2 in transforming growth
factor β-Induced hypertrophy of ligamentum flavum. World Neurosurg.
151:e128–e136. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cui G, Watanabe K, Miyauchi Y, Hosogane N,
Tsuji T, Ishii K, Nakamura M, Toyama Y, Chiba K, Miyamoto T and
Matsumoto M: Matrix metalloproteinase 13 in the ligamentum flavum
from lumbar spinal canal stenosis patients with and without
diabetes mellitus. J Orthop Sci. 16:785–790. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xue YM, Deng CY, Wei W, Liu FZ, Yang H,
Liu Y, Li X, Wang Z, Kuang SJ, Wu SL and Rao F: Macrophage
migration inhibitory factor promotes cardiac fibroblast
proliferation through the Src kinase signaling pathway. Mol Med
Rep. 17:3425–3431. 2018.PubMed/NCBI
|
|
11
|
Zheng Y, Li X, Qian X, Wang Y, Lee JH, Xia
Y, Hawke DH, Zhang G, Lyu J and Lu Z: Secreted and O-GlcNAcylated
MIF binds to the human EGF receptor and inhibits its activation.
Nat Cell Biol. 17:1348–1355. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yao Y, Deng Q, Song W, Zhang H, Li Y, Yang
Y, Fan X, Liu M, Shang J, Sun C, et al: MIF plays a key role in
regulating tissue-specific chondro-osteogenic differentiation fate
of human cartilage endplate stem cells under hypoxia. Stem Cell
Reports. 7:249–262. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hertelendy J, Reumuth G, Simons D, Stoppe
C, Kim BS, Stromps JP, Fuchs PC, Bernhagen J, Pallua N and Grieb G:
Macrophage migration inhibitory factor-a favorable marker in
inflammatory diseases? Curr Med Chem. 25:601–605. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lu QL, Wang XZ, Xie W, Chen XW, Zhu YL and
Li XG: Macrophage migration inhibitory factor may contribute to
hypertrophy of lumbar ligamentum flavum in type 2 diabetes
mellitus. Chin Med J (Engl). 133:623–625. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Arocho A, Chen B, Ladanyi M and Pan Q:
Validation of the 2-DeltaDeltaCt calculation as an alternate method
of data analysis for quantitative PCR of BCR-ABL P210 transcripts.
Diagn Mol Pathol. 15:56–61. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sun C, Zhang H, Wang X and Liu X:
Ligamentum flavum fibrosis and hypertrophy: Molecular pathways,
cellular mechanisms and future directions. FASEB J. 34:9854–9868.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Takeda H, Nagai S, Ikeda D, Kaneko S,
Tsuji T and Fujita N: Collagen profiling of ligamentum flavum in
patients with lumbar spinal canal stenosis. J Orthop Sci.
26:560–565. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kosaka H, Sairyo K, Biyani A, Leaman D,
Yeasting R, Higashino K, Sakai T, Katoh S, Sano T, Goel VK and
Yasui N: Pathomechanism of loss of elasticity and hypertrophy of
lumbar ligamentum flavum in elderly patients with lumbar spinal
canal stenosis. Spine (Phila Pa 1976). 32:2805–2811. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Melancia JL, Francisco AF and Antunes JL:
Spinal stenosis. Handb Clin Neurol. 119:541–549. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yan B, Zeng C, Chen Y, Huang M, Yao N,
Zhang J, Yan B, Tang J, Wang L and Zhang Z: Mechanical
Stress-Induced IGF-1 Facilitates col-I and col-III Synthesis via
the IGF-1R/AKT/mTORC1 Signaling Pathway. Stem Cells Int.
2021:55536762021. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sun C, Wang Z, Tian JW and Wang YH:
Leptin-induced inflammation by activating IL-6 expression
contributes to the fibrosis and hypertrophy of ligamentum flavum in
lumbar spinal canal stenosis. Biosci Rep. 38:BSR201712142018.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen MH, Hu CK, Chen PR, Chen YS, Sun JS
and Chen MH: Dose-dependent regulation of cell proliferation and
collagen degradation by estradiol on ligamentum flavum. BMC
Musculoskelet Disord. 15:2382014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sudhir G, Vignesh Jayabalan S, Gadde S,
Venkatesh Kumar G and Karthik Kailash K: Analysis of factors
influencing ligamentum flavum thickness in lumbar spine-A
radiological study of 1070 disc levels in 214 patients. Clin Neurol
Neurosurg. 182:19–24. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kasama T, Ohtsuka K, Sato M, Takahashi R,
Wakabayashi K and Kobayashi K: Macrophage migration inhibitory
factor: A multifunctional cytokine in rheumatic diseases.
Arthritis. 2010:1062022010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sugimoto K, Nakamura T, Tokunaga T, Uehara
Y, Okada T, Taniwaki T, Fujimoto T and Mizuta H: Matrix
metalloproteinase promotes elastic fiber degradation in ligamentum
flavum degeneration. PLoS One. 13:e02008722018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Onodera S, Nishihira J, Koyama Y, Majima
T, Aoki Y, Ichiyama H, Ishibashi T and Minami A: Macrophage
migration inhibitory factor up-regulates the expression of
interleukin-8 messenger RNA in synovial fibroblasts of rheumatoid
arthritis patients: Common transcriptional regulatory mechanism
between interleukin-8 and interleukin-1beta. Arthritis Rheum.
50:1437–1447. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Leng L and Bucala R: Macrophage migration
inhibitory factor. Crit Care Med. 33 (12 Suppl):S475–S477. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Su Y and Wang Y, Zhou Y, Zhu Z, Zhang Q,
Zhang X, Wang W, Gu X, Guo A and Wang Y: Macrophage migration
inhibitory factor activates inflammatory responses of astrocytes
through interaction with CD74 receptor. Oncotarget. 8:2719–2730.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li H, Zhao C, Tian Y, Lu J, Zhang G, Liang
S, Chen D, Liu X, Kuang W and Zhu M: Src family kinases and
pulmonary fibrosis: A review. Biomed Pharmacother. 127:1101832020.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Koudelková L, Brábek J and Rosel D: Src
kinase: Key effector in mechanosignalling. Int J Biochem Cell Biol.
131:1059082021. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ntanasis-Stathopoulos I, Fotopoulos G,
Tzanninis IG and Kotteas EA: The emerging role of tyrosine kinase
inhibitors in ovarian cancer treatment: A systematic review. Cancer
Invest. 34:313–339. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Rao F, Deng CY, Wu SL, Xiao DZ, Yu XY,
Kuang SJ, Lin QX and Shan ZX: Involvement of Src in L-type Ca2+
channel depression induced by macrophage migration inhibitory
factor in atrial myocytes. J Mol Cell Cardiol. 47:586–594. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Cai T, Kuang Y, Zhang C, Zhang Z, Chen L,
Li B, Li Y, Wang Y, Yang H, Han Q and Zhu Y: Glucose-6-phosphate
dehydrogenase and NADPH oxidase 4 control STAT3 activity in
melanoma cells through a pathway involving reactive oxygen species,
c-SRC and SHP2. Am J Cancer Res. 5:1610–1620. 2015.PubMed/NCBI
|
|
34
|
Zernecke A, Bernhagen J and Weber C:
Macrophage migration inhibitory factor in cardiovascular disease.
Circulation. 117:1594–1602. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Jankauskas SS, Wong DWL, Bucala R, Djudjaj
S and Boor P: Evolving complexity of MIF signaling. Cell Signal.
57:76–88. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Presti M, Mazzon E, Basile MS and Maria
CP: Overexpression of macrophage migration inhibitory factor and
functionally-related genes, D-DT, CD74, CD44, CXCR2 and CXCR4, in
glioblastoma. Oncol Lett. 16:2881–2886. 2018.PubMed/NCBI
|
